Lemonade shares declined by 6.5% on Friday, trading down to intraday lows before settling at approximately three points below Thursday’s close. Midday volume totaled 227,836 shares, representing a 91% drop from the 2.43 million average session volume. This sudden reduction in turnover underscores a notable pullback in trading interest following recent volatility.

Over the past quarter, eight analysts updated their outlooks on Lemonade: one maintained a strong buy, two issued buy ratings, two held neutral, and three applied sell opinions. The consensus rating remains Hold, with the average price target standing at 63.14. Notable moves include Piper Sandler reducing its target from 60 to 55 and Keefe, Bruyette & Woods raising its target from 35 to 40 despite an underperform recommendation.

In its most recent quarterly report, Lemonade posted revenue of 194.5 million, surpassing estimates by over 9 million and marking a 42.4% year-over-year increase. Adjusted loss per share of 0.51 beat expectations by 0.21. However, the company still reported a negative return on equity of 31.86% and a net margin deficit of 26.39%. Analysts project a full-year EPS loss of approximately 3.03, while the firm’s market capitalization stands near 5.6 billion with a beta of 2.13 and a trailing negative price-earnings ratio of 31.28.

Insiders have sold 160,725 shares valued at over 12.26 million in the past 90 days, reducing collective holdings by nearly one-fifth; current insider ownership is 14.70%. Among institutions, Vanguard increased its stake by 0.9% to 6.28 million shares, JPMorgan Chase added 30.8% to reach 3.51 million shares, and BIT Capital expanded by 69.3% to 1.25 million. Hedge funds and other institutions now own 80.30% of the company’s shares.